High-grade Pelvic Serous Carcinoma Within the Fallopian Tube Lumen: Real or Artifact?

Tumor cells are occasionally observed in the lumen in histologic sections of the fallopian tube from women with gynecologic cancer. There is some evidence that this finding may be important in endometrial cancer, but its significance is unknown in women with extrauterine pelvic serous carcinomas (tubo-ovarian high-grade serous carcinoma). Fallopian tube sections from 213 women with extrauterine pelvic serous carcinoma were reviewed, and luminal tumor cells were correlated with clinical and pathologic features. Intraluminal tumor cells were found in 84 patients (39%). The presence or absence of luminal tumor cells correlated significantly with serous tubal intraepithelial carcinoma (52% and 33%, respectively, P=0.004), tubal lymphatic invasion (32% and 12%, respectively, P=0.0002), and number of tube sections reviewed (6.6 and 4.9 for lumen-positive and lumen-negative cases, respectively, P=0.0056). There was no correlation with the presence of ascites, peritoneal cytopathologic findings, lymph node metastases, or FIGO stage. In the setting of pelvic serous carcinoma, a substantial portion of fallopian tube tissue is often distorted, fibrotic, and difficult to identify. Since the identification of luminal tumor cells, serous tubal intraepithelial carcinoma and tubal lymphatic invasion all depend on identification of fallopian tube tissue, these correlates with luminal tumor cells could be a result of a higher likelihood of their observation when tubal tissue can be more readily identified and may not necessarily reflect a biologically important phenomenon. It remains unclear whether and in what proportion this finding reflects an artifact of specimen handling.

[1]  J. Seidman,et al.  Lymphatic Invasion in the Fallopian Tube is a Late Event in the Progression of Pelvic Serous Carcinoma and Correlates With Distant Metastasis , 2020, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[2]  R. Kurman,et al.  Intratumoral Heterogeneity Accounts for Apparent Progression of Noninvasive Serous Tumors to Invasive Low-grade Serous Carcinoma: A Study of 30 Low-grade Serous Tumors of the Ovary in 18 Patients With Peritoneal Carcinomatosis , 2020, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[3]  Naveena Singh,et al.  Pathologic Prognostic Factors in Endometrial Carcinoma (Other Than Tumor Type and Grade) , 2018, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[4]  E. Oliva,et al.  Current Practices in the Processing, Diagnosis, and Reporting of Endometrial Carcinoma: Results of a Web-based Survey by the International Society of Gynecological Pathologists (ISGyP) , 2018, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[5]  Naveena Singh,et al.  Endometrial Carcinoma, Grossing and Processing Issues: Recommendations of the International Society of Gynecologic Pathologists , 2018, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[6]  E. Oliva,et al.  Guidelines to Aid in the Distinction of Endometrial and Endocervical Carcinomas, and the Distinction of Independent Primary Carcinomas of the Endometrium and Adnexa From Metastatic Spread Between These and Other Sites , 2018, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[7]  M. Sherman,et al.  Detection of endometrial cancer cells in the fallopian tube lumen is associated with adverse prognostic factors and reduced survival. , 2018, Gynecologic oncology.

[8]  G. Mills,et al.  Fallopian tube precursor lesions of serous ovarian carcinoma require L1CAM for dissemination and metastasis , 2018, bioRxiv.

[9]  E. Ratner,et al.  Associated characteristics and impact on recurrence and survival of free-floating tumor fragments in the lumen of fallopian tubes in Type I and Type II endometrial cancer , 2018, Gynecologic oncology reports.

[10]  Kathleen R. Cho,et al.  The disparate origins of ovarian cancers: pathogenesis and prevention strategies , 2016, Nature Reviews Cancer.

[11]  I. Shih,et al.  The Dualistic Model of Ovarian Carcinogenesis: Revisited, Revised, and Expanded. , 2016, The American journal of pathology.

[12]  Richard G. Moore,et al.  Relationships of Tubal Ligation to Endometrial Carcinoma Stage and Mortality in the NRG Oncology/ Gynecologic Oncology Group 210 Trial. , 2015, Journal of the National Cancer Institute.

[13]  J. Seidman Serous Tubal Intraepithelial Carcinoma Localizes to the Tubal-peritoneal Junction: A Pivotal Clue to the Site of Origin of Extrauterine High-grade Serous Carcinoma (Ovarian Cancer) , 2015, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[14]  J. Seidman,et al.  Distribution and case-fatality ratios by cell-type for ovarian carcinomas: a 22-year series of 562 patients with uniform current histological classification. , 2015, Gynecologic oncology.

[15]  J. Rabban,et al.  Nongynecologic Metastases to Fallopian Tube Mucosa: A Potential Mimic of Tubal High-grade Serous Carcinoma and Benign Tubal Mucinous Metaplasia or Nonmucinous Hyperplasia , 2015, The American journal of surgical pathology.

[16]  Gregory A. Wyant,et al.  Transformation of the fallopian tube secretory epithelium leads to high-grade serous ovarian cancer in Brca;Tp53;Pten models. , 2013, Cancer cell.

[17]  J. Seidman The Presence of Mucosal Iron in the Fallopian Tube Supports the “Incessant Menstruation Hypothesis” for Ovarian Carcinoma , 2013, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[18]  P. V. van Diest,et al.  Fallopian Tube Intraluminal Tumor Spread From Noninvasive Precursor Lesions: A Novel Metastatic Route in Early Pelvic Carcinogenesis , 2013, The American journal of surgical pathology.

[19]  D. Doherty,et al.  Transtubal spread of endometrial carcinoma: correlation of intra-luminal tumour cells with tumour grade, peritoneal fluid cytology, and extra-uterine metastasis , 2013, Pathology.

[20]  R. Barakat,et al.  Tumoral Displacement into Fallopian Tubes in Patients Undergoing Robotically Assisted Hysterectomy for Newly Diagnosed Endometrial Cancer , 2013, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[21]  H. Duan,et al.  Effect of hysteroscopy on the peritoneal dissemination of endometrial cancer cells: a meta-analysis. , 2011, Fertility and sterility.

[22]  B. Clarke,et al.  Histologic Artifacts in Abdominal, Vaginal, Laparoscopic, and Robotic Hysterectomy Specimens: A Blinded, Retrospective Review , 2011, The American journal of surgical pathology.

[23]  I. Hammond,et al.  Coexisting serous carcinoma of the endometrium and the fallopian tube. , 2010, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[24]  J. Seidman,et al.  Exploring the histogenesis of ovarian mucinous and transitional cell (Brenner) neoplasms and their relationship with Walthard cell nests: a study of 120 tumors. , 2008, Archives of pathology & laboratory medicine.

[25]  Allan G. Rempel,et al.  Chromosomal instability in fallopian tube precursor lesions of serous carcinoma and frequent monoclonality of synchronous ovarian and fallopian tube mucosal serous carcinoma. , 2008, Gynecologic oncology.

[26]  R. Bentley,et al.  Transtubal Spread of Serous Adenocarcinoma of the Endometrium: An Underrecognized Mechanism of Metastasis , 2006, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[27]  M. Sherman,et al.  Salpingitis, Salpingoliths, and Serous Tumors of the Ovaries: Is There a Connection? , 2002, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[28]  L. Jordan,et al.  Uterine serous papillary carcinoma: Histopathologic changes within the female genital tract , 2001, International Journal of Gynecologic Cancer.

[29]  M. Sherman,et al.  Minimal uterine serous carcinoma: diagnosis and clinicopathologic correlation. , 2000, The American journal of surgical pathology.

[30]  M. Aickin,et al.  Adjusting for multiple testing when reporting research results: the Bonferroni vs Holm methods. , 1996, American journal of public health.

[31]  M. Sherman,et al.  Uterine Serous Carcinoma A Morphologically Diverse Neoplasm With Unifying Clinicopathologic Features , 1992, The American journal of surgical pathology.

[32]  J. Cragun,et al.  Primary sources of pelvic serous cancer in patients with endometrial intraepithelial carcinoma , 2015, Modern Pathology.

[33]  Tina A. Ayeni,et al.  Impact of tubal ligation on routes of dissemination and overall survival in uterine serous carcinoma. , 2013, Gynecologic oncology.

[34]  J. Sampson Carcinoma of the Tubes and Ovaries Secondary to Carcinoma of the Body of the Uterus. , 1934, The American journal of pathology.